Investment Banking Analyst - Technology Team

Sage Healthcare and Roth Capital Partners announce European healthcare collaboration. Connecting European healthcare innovators with Sage's transaction expertise and Roth's U.S. capital markets platform to support financing and strategic growth This powerful collaboration allows Healthcare Industry Today to explore with European healthcare and life science companies where Sage's network and capabilities can complement Roth's US capital markets expertise." - Dr. Bill Mason LONDON, UNITED KINGDOM, October 8, 2026 / EINPresswire.com / - London, United Kingdom & Newport Beach, California. Sage Healthcare Ltd ("Sage") and Roth Capital Partners, LLC ("Roth") have announced a strategic collaboration to identify and assess European healthcare and life-science companies that may benefit from experienced transaction advice and U.S. capital markets expertise. Sage will contribute access to its European network, transaction experience and SAGEIQ(TM), its AI-enabled deep market analysis capability. Roth will provide access to its healthcare investment banking, financing strategy and U.S. capital markets services, subject to its compliance and client-acceptance procedures. Management Commentary "European healthcare and life-science companies often need strategic transaction advice alongside U.S. capital markets expertise," said Dr. William Mason, Director of Sage Healthcare Ltd. "This collaboration allows us to explore where Sage's network and experience can complement Roth's platform." "Sage's experience, European network and intelligence capabilities can identify companies that could benefit from Roth's healthcare investment banking and U.S. capital markets expertise," said Dr. Ben Bowen, Managing Director, Investment Banking at Roth Capital Partners. "We look forward to assessing relevant opportunities together." About Sage Healthcare Ltd Sage Healthcare Ltd is a specialist healthcare and life-science transaction advisory firm supporting licensing, partnering and M&A. Its SAGEIQ(TM) capability supports company and partner prioritisation. About Roth Capital Partners, LLC Roth Capital Partners, LLC is a Newport Beach-based investment banking and capital markets firm providing financing and strategic financial advisory services to healthcare growth companies. Sage Healthcare Ltd Dr. William Mason Email: [email protected] Roth Capital Partners, LLC Dr. Ben Bowen Managing Director, Investment Banking Email: [email protected] Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Healthcare Industry Today do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Companies from uranium mining to fusion meet institutional investors at the Inaugural ROTH Emerging Nuclear Technology Conference. Posted on September 30, 2026 NEW YORK, NY Keynote, fireside chat, lunch panel and a full day of investor meetings at 1 Hotel Central Park in New York City, October 1. Uranium mining, fuel cycle, small modular reactors, microreactors, used-fuel management and fusion. B2i Digital, Inc. is the Marketing Partner for the Inaugural ROTH Emerging Nuclear Technology Conference, a B2i Digital Featured Conference hosted by ROTH Capital Partners at 1 Hotel Central Park in New York City on Thursday, October 1, 2026. B2i Digital highlights the conference and the participating companies to a media network with a monthly audience of 330 million and a community of 1.7 million investors. The conference puts institutional investors in the room with public and private companies from across the nuclear industry. Meetings run one-on-one and in small groups from 9:00 AM to noon and from 1:30 to 4:00 PM. Jay Yu, Founder and Executive Chairman of NANO Nuclear Energy Inc. (Nasdaq: NNE), opens the day with a keynote at 8:40 AM. Over the working lunch, Craig Irwin, Managing Director and Senior Research Analyst for Sustainability at ROTH, moderates a 12:05 PM fireside chat with Kevin McGurn, Interim Chief Executive Officer of Trump Media & Technology Group Corp. (Nasdaq: DJT), TAE Technologies' pending merger partner. A panel with executives from Hadron Energy, Deep Isolation, SuperCritical Materials and Terra Innovatum follows at 12:45 PM. A cocktail reception closes the day at 4:00 PM. "Two ROTH conferences in New York in 3 days, healthcare on Tuesday and nuclear on Thursday. ROTH's conference lineup is nothing short of impressive and covers all the key sectors of interest to our investors. A big shout out to Isabel Mattson-Pain and her team for all the hard work it takes to pull it off. The nuclear day focuses on meetings with institutional investors, with a keynote to start and a panel over lunch. Uranium miners, fuel, reactors, used fuel and fusion in one room. Every conversation about AI includes the question, how do we power the demand for it? These are the companies working on the answer," said David Shapiro, Chief Executive Officer of B2i Digital. This is an invitation-only event and registration is subject to approval by ROTH. To request registration: https://www.meetmax.com/sched/event_146891/conference_home.html or email [email protected]. Confirmed participants as of September 28, 2026 (subject to change): Anfield Energy Inc. (Nasdaq: AEC | TSXV: AEC) develops uranium and vanadium projects in Utah, Colorado, Arizona and New Mexico and owns the Shootaring Canyon Mill in Utah. Denison Mines Corp. (NYSE American: DNN | TSX: DML) is a uranium mining, development and exploration company focused on the Athabasca Basin in northern Saskatchewan, home to its Wheeler River project. Jaguar Uranium Corp. (NYSE American: JAGU) is developing uranium assets in Argentina and Colombia. Uranium Energy Corp. (NYSE American: UEC) is a U.S. uranium producer with in-situ recovery hub-and-spoke platforms in Wyoming and South Texas. Centrus Energy Corp. (NYSE: LEU) supplies nuclear fuel and services to the nuclear power industry and produces high-assay, low-enriched uranium (HALEU) in Piketon, Ohio. SuperCritical Materials Corp. (private) is developing industrial-scale nuclear fuel production infrastructure to expand future fuel availability. Deep Fission, Inc. (Nasdaq: FISN) is developing small modular pressurized water reactors designed to operate a mile underground. Terrestrial Energy Inc. (Nasdaq: IMSR) is developing the Integral Molten Salt Reactor (IMSR) plant, a Generation IV small modular reactor for industrial heat and power. Hadron Energy, Inc. (Nasdaq: HDRN) is developing Halo, a micro modular reactor designed for factory manufacturing and deployment at data centers and critical infrastructure. NANO Nuclear Energy Inc. (Nasdaq: NNE) develops microreactors, including the KRONOS MMR and ZEUS, alongside nuclear fuel fabrication and transportation businesses. Terra Innovatum Global N.V. (Nasdaq: NKLR) is developing SOLO, a micro-modular reactor for data centers, remote communities, mining, defense and other off-grid users. Deep Isolation Nuclear, Inc. (OTCQB: DBHL) develops permanent disposal solutions for spent nuclear fuel using directional boreholes drilled deep into host rock. TAE Technologies, Inc. (private) was founded in 1998 to develop commercial fusion power, is based in Foothill Ranch, California, and has agreed to merge with Trump Media & Technology Group Corp. (Nasdaq: DJT). Air Force Office of Energy Assurance (private) identifies and develops energy resilience solutions for Department of the Air Force installations. About ROTH Capital Partners ROTH is a relationship-driven investment bank focused on serving growth companies and their investors. Its full-service platform provides capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory and corporate access. Headquartered in Newport Beach, California, ROTH is a privately held, employee-owned organization maintaining offices throughout the United States. For more information, visit https://www.roth.com. About B2i Digital, Inc. B2i Digital, Inc. partners with conferences, public companies, and capital markets advisors through its Featured Conference, Featured Company, and Featured Expert programs. Its media network spans 800+ news, broadcast, and trade outlets with a 330 million+ combined monthly audience, plus 1.7 million+ followers, 70,000 opt-in email subscribers, and a rolodex of 235,000+ capital markets contacts. That reach gets clients seen; its conferences put them in the room with investors. The Capital Markets Matchmaker(SM) takes every story From Marketing to Meetings(SM). B2i Digital is headquartered in New York City. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital Contact Information David Shapiro | Chief Executive Officer | B2i Digital, Inc. https://b2idigital.com | 212.579.4844 Office | [email protected] | https://www.linkedin.com/in/davidshapironyc Disclosure & Disclaimer B2i Digital, Inc. is the Marketing Partner of the Inaugural ROTH Emerging Nuclear Technology Conference. B2i Digital, Inc. is not an affiliate of ROTH Capital Partners, LLC and is not authorized to represent or act on behalf of ROTH in any capacity. Content related to any specific company referenced in this release was provided by that company, approved by that company, or obtained from publicly available sources. B2i Digital, Inc. has not independently verified the accuracy or completeness of such information, and no representation or warranty, express or implied, is made as to its accuracy. This content is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security, nor should it be relied upon as the basis for any investment decision. B2i Digital, Inc. is not a registered broker-dealer, investment adviser, or financial adviser, and nothing herein should be construed as investment, legal, tax, or accounting advice. Readers should consult their own advisers and conduct their own due diligence before making any investment decision. Related Items: